These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16131588)

  • 1. Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization.
    Levy M; Griswold KE; Ellington AD
    RNA; 2005 Oct; 11(10):1555-62. PubMed ID: 16131588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of novel ribozymes that ligate AMP-activated RNA substrates.
    Hager AJ; Szostak JW
    Chem Biol; 1997 Aug; 4(8):607-17. PubMed ID: 9281527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial ligase ribozymes isolated by a "design and selection" strategy.
    Matsumura S; Ikawa Y
    Methods Mol Biol; 2015; 1316():113-25. PubMed ID: 25967057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA.
    Ishizaka M; Ohshima Y; Tani T
    Biochem Biophys Res Commun; 1995 Sep; 214(2):403-9. PubMed ID: 7545903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ligase ribozyme obtained from a structured pool.
    Yoshioka W; Ikawa Y; Jaeger L; Inoue T
    Nucleic Acids Symp Ser (Oxf); 2004; (48):209-10. PubMed ID: 17150552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinated control of a designed trans-acting ligase ribozyme by a loop-receptor interaction.
    Matsumura S; Ohmori R; Saito H; Ikawa Y; Inoue T
    FEBS Lett; 2009 Sep; 583(17):2819-26. PubMed ID: 19631647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A class I ligase ribozyme with reduced Mg2+ dependence: Selection, sequence analysis, and identification of functional tertiary interactions.
    Bagby SC; Bergman NH; Shechner DM; Yen C; Bartel DP
    RNA; 2009 Dec; 15(12):2129-46. PubMed ID: 19946040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of hammerhead ribozymes containing a bulged nucleotide in stem II.
    Thomson JB; Sigurdsson ST; Zeuch A; Eckstein F
    Nucleic Acids Res; 1996 Nov; 24(22):4401-6. PubMed ID: 8948630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of catalytic parameters for hairpin ribozymes.
    DeYoung MB; Siwkowski A; Hampel A
    Methods Mol Biol; 1997; 74():209-20. PubMed ID: 9204436
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization and optimality of a short ribozyme ligase that joins non-Watson-Crick base pairings.
    Robertson MP; Hesselberth JR; Ellington AD
    RNA; 2001 Apr; 7(4):513-23. PubMed ID: 11345430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-splicing reactions by ribozymes.
    Jones JT; Lee SW; Sullenger BA
    Methods Mol Biol; 1997; 74():341-8. PubMed ID: 9204448
    [No Abstract]   [Full Text] [Related]  

  • 13. The secondary structure and sequence optimization of an RNA ligase ribozyme.
    Ekland EH; Bartel DP
    Nucleic Acids Res; 1995 Aug; 23(16):3231-8. PubMed ID: 7667099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of ribozymes that catalyse multiple-turnover Diels-Alder cycloadditions by using in vitro compartmentalization.
    Agresti JJ; Kelly BT; Jäschke A; Griffiths AD
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16170-5. PubMed ID: 16260754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ribozyme composed of only two different nucleotides.
    Reader JS; Joyce GF
    Nature; 2002 Dec 19-26; 420(6917):841-4. PubMed ID: 12490955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of hammerhead ribozymes with altered core sequences by in vitro selection.
    Vaish NK; Heaton PA; Eckstein F
    Biochemistry; 1997 May; 36(21):6495-501. PubMed ID: 9174367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded divalent metal-ion tolerance of evolved ligase ribozymes.
    Riley CA; Lehman N
    Biochimie; 2003 Jul; 85(7):683-9. PubMed ID: 14505824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.